- Regulating
Biotechnologies: Preliminary Inquiry
- International
Models (Comparative [Knowles], Canada [Baird])
- Patentability
of Human Organisms (History [Kevles], Policy [Hauda])
- Patentability
of Human Organisms (Holtzman, Kimbrell, Rai)
- Patentability
of Human Organisms (General Discussion)
- Institutional
Review Boards (IRBs) (Emanuel)
- International
Models (Germany [Simitis])
- International
Models (United Kingdom [Kennedy])
- International
Models (United Kingdom [Leather])
- General Discussion
- Assisted
Reproductive Technologies in the Genomics Era (Schatten)
- Role of the
Food and Drug Administration (FDA) (Legal [Merrill], Institutional
[Benson])
- Professional
Self-Regulation (ASRM)
- Professional
Self-Regulation (Annas)
- Public Panel
I (Assisted Reproduction and Reproductive Genetics) (Madsen,
Mahowald, Brzyski, Hudson, andSmith)
- Public Panel
II (Embryo and Related Research) (Manganiello, Doerflinger,
Singer, Werner, Kimbrell, and Kristol)
- Discussion
Document on the U.S. Regulatory Landscape: Part I (ART,
Preimplantation Genetic Diagnosis)
- Discussion
Document on the U.S. Regulatory Landscape: Part II (Genetic
Engineering, Embryo Research, Commodification)
- Stem Cell
Research: Current Law and Policy with Emphasis on the States
(Andrews)
- Discussion
of Findings and Identification of Policy Options
- Proposed
Interim Recommendations, I
- Proposed
Interim Recommendations, II
- Chimeras
and the Boundaries of the Human
- Proposed
Interim Recommendations, III, IV
- Proposed
Interim Recommendations, V
- Draft Recommendations,
Revised
- Council's
Report to the President
- Biotechnology
and Public Policy (Fukuyama)
- The New Canadian
System (Shugart)
- Human-Animal
Chimeras (Council Discussion)
|
